The enrichment analysis of these hub genes demonstrated that they are highly correlated with the adverse outcome pathway of COVID-19, the overview of pro-inflammatory and pro-fibrotic mediators, and the interleukin-10 signaling pathway. This evidence concerns the gene IL10 and COVID-19.